Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6174 Target Snapshot

Cytochrome c oxidase subunit 2 · SINGLE PROTEIN · Homo sapiens

198Compounds
47Assays
5Approved Drugs
117.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P00403. Use UniProt P00403 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P00403 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome c oxidase subunit 2 as ChEMBL target CHEMBL6174, mapped to UniProt P00403. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome c oxidase subunit 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL6174
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P00403
Cytochrome c oxidase subunit 2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome c oxidase subunit 2 is the right protein anchor across sources, using UniProt P00403 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome c oxidase subunit 2
UniProt AccessionP00403
Component TypeProtein
Sequence Length227 aa

Cytochrome c oxidase subunit 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome c oxidase subunit 2, mapped to UniProt P00403. Sequence length is 227 aa.

Mapped IDP00403
Review nameCytochrome c oxidase subunit 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

5
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC50114.0
KI1.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL122 7.7 IC50 20.0 Approved
CHEMBL42485 7.68 IC50 21.0 Preclinical
CHEMBL441414 7.58 IC50 26.0 Preclinical
CHEMBL254418 7.4 IC50 40.0 Preclinical
CHEMBL5568253 7.24 IC50 58.0 Preclinical
CHEMBL6 7.16 IC50 70.0 Approved
CHEMBL5565096 7.12 IC50 75.0 Preclinical
CHEMBL5568511 6.87 IC50 134.0 Preclinical
CHEMBL5568474 6.84 IC50 144.0 Preclinical
CHEMBL5653589 6.81 Kd 153.48 Preclinical
Distribution

pChEMBL Value Distribution

22
5.0
13
5.5
12
6.0
8
6.5
4
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ROFECOXIB
CHEMBL122
Approved 1999
CELECOXIB
CHEMBL118
Approved 1998
INDOMETHACIN
CHEMBL6
Approved 1965
Assay Landscape

Assay Landscape

47
Total Assays
77
Tested Compounds
3
Assay Types
Binding — 41 assays, 77 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 31 56 5.8
cell-based format 7 20 5.0
assay format 2 0
tissue-based format 1 1 6.5
ADME — 5 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 0
cell-based format 1 0
Toxicity — 1 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 2 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine